REPORT ID 2469

Global Candidiasis Therapeutics Market Professional Survey Report 2017

Publish Date
8-Dec-17
Pages
114
Format
Electronic (PDF)

This report studies Candidiasis Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Novartis AG
    Amgen
    F. Hoffmann-La Roche Ltd.
    Bayer-Algeta
    Merrion Pharmaceuticals Plc.
    Ablynx
    Genta Incorporated
    Galapagos NV
    Catena Pharmaceuticals Inc.
    Digna Biotech S.L.
    Medivir AB
    Amura Holdings

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Doxorubicin
    Cisplatin
    7Carboplatin
    Etoposide
    Ifosfamide
    Cyclophosphamide
    Methotrexate
    Vincristine

By Application, the market can be split into
    Multispecialty Hospitals
    Cancer Research Institutes
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Candidiasis Therapeutics Market Professional Survey Report 2017
1 Industry Overview of Candidiasis Therapeutics
    1.1 Definition and Specifications of Candidiasis Therapeutics
        1.1.1 Definition of Candidiasis Therapeutics
        1.1.2 Specifications of Candidiasis Therapeutics
    1.2 Classification of Candidiasis Therapeutics
        1.2.1 Doxorubicin
        1.2.2 Cisplatin
        1.2.3 7Carboplatin
        1.2.4 Etoposide
        1.2.5 Ifosfamide
        1.2.6 Cyclophosphamide
        1.2.7 Methotrexate
        1.2.8 Vincristine
    1.3 Applications of Candidiasis Therapeutics
        1.3.1 Multispecialty Hospitals
        1.3.2 Cancer Research Institutes
        1.3.3 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Candidiasis Therapeutics
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Candidiasis Therapeutics
    2.3 Manufacturing Process Analysis of Candidiasis Therapeutics
    2.4 Industry Chain Structure of Candidiasis Therapeutics

3 Technical Data and Manufacturing Plants Analysis of Candidiasis Therapeutics
    3.1 Capacity and Commercial Production Date of Global Candidiasis Therapeutics Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Candidiasis Therapeutics Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Candidiasis Therapeutics Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Candidiasis Therapeutics Major Manufacturers in 2016

4 Global Candidiasis Therapeutics Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Candidiasis Therapeutics Capacity and Growth Rate Analysis
        4.2.2 2016 Candidiasis Therapeutics Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Candidiasis Therapeutics Sales and Growth Rate Analysis
        4.3.2 2016 Candidiasis Therapeutics Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Candidiasis Therapeutics Sales Price
        4.4.2 2016 Candidiasis Therapeutics Sales Price Analysis (Company Segment)

5 Candidiasis Therapeutics Regional Market Analysis
    5.1 North America Candidiasis Therapeutics Market Analysis
        5.1.1 North America Candidiasis Therapeutics Market Overview
        5.1.2 North America 2012-2017E Candidiasis Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Candidiasis Therapeutics Sales Price Analysis
        5.1.4 North America 2016 Candidiasis Therapeutics Market Share Analysis
    5.2 China Candidiasis Therapeutics Market Analysis
        5.2.1 China Candidiasis Therapeutics Market Overview
        5.2.2 China 2012-2017E Candidiasis Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Candidiasis Therapeutics Sales Price Analysis
        5.2.4 China 2016 Candidiasis Therapeutics Market Share Analysis
    5.3 Europe Candidiasis Therapeutics Market Analysis
        5.3.1 Europe Candidiasis Therapeutics Market Overview
        5.3.2 Europe 2012-2017E Candidiasis Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Candidiasis Therapeutics Sales Price Analysis
        5.3.4 Europe 2016 Candidiasis Therapeutics Market Share Analysis
    5.4 Southeast Asia Candidiasis Therapeutics Market Analysis
        5.4.1 Southeast Asia Candidiasis Therapeutics Market Overview
        5.4.2 Southeast Asia 2012-2017E Candidiasis Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Candidiasis Therapeutics Sales Price Analysis
        5.4.4 Southeast Asia 2016 Candidiasis Therapeutics Market Share Analysis
    5.5 Japan Candidiasis Therapeutics Market Analysis
        5.5.1 Japan Candidiasis Therapeutics Market Overview
        5.5.2 Japan 2012-2017E Candidiasis Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Candidiasis Therapeutics Sales Price Analysis
        5.5.4 Japan 2016 Candidiasis Therapeutics Market Share Analysis
    5.6 India Candidiasis Therapeutics Market Analysis
        5.6.1 India Candidiasis Therapeutics Market Overview
        5.6.2 India 2012-2017E Candidiasis Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Candidiasis Therapeutics Sales Price Analysis
        5.6.4 India 2016 Candidiasis Therapeutics Market Share Analysis

6 Global 2012-2017E Candidiasis Therapeutics Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Candidiasis Therapeutics Sales by Type
    6.2 Different Types of Candidiasis Therapeutics Product Interview Price Analysis
    6.3 Different Types of Candidiasis Therapeutics Product Driving Factors Analysis
        6.3.1 Doxorubicin of Candidiasis Therapeutics Growth Driving Factor Analysis
        6.3.2 Cisplatin of Candidiasis Therapeutics Growth Driving Factor Analysis
        6.3.3 7Carboplatin of Candidiasis Therapeutics Growth Driving Factor Analysis
        6.3.4 Etoposide of Candidiasis Therapeutics Growth Driving Factor Analysis
        6.3.5 Ifosfamide of Candidiasis Therapeutics Growth Driving Factor Analysis
        6.3.6 Cyclophosphamide of Candidiasis Therapeutics Growth Driving Factor Analysis
        6.3.7 Methotrexate of Candidiasis Therapeutics Growth Driving Factor Analysis
        6.3.8 Vincristine of Candidiasis Therapeutics Growth Driving Factor Analysis

7 Global 2012-2017E Candidiasis Therapeutics Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Candidiasis Therapeutics Consumption by Application
    7.2 Different Application of Candidiasis Therapeutics Product Interview Price Analysis
    7.3 Different Application of Candidiasis Therapeutics Product Driving Factors Analysis
        7.3.1 Multispecialty Hospitals of Candidiasis Therapeutics Growth Driving Factor Analysis
        7.3.2 Cancer Research Institutes of Candidiasis Therapeutics Growth Driving Factor Analysis
        7.3.3 Others of Candidiasis Therapeutics Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Candidiasis Therapeutics
    8.1 Novartis AG
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Novartis AG 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Novartis AG 2016 Candidiasis Therapeutics Business Region Distribution Analysis
    8.2 Amgen
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Amgen 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Amgen 2016 Candidiasis Therapeutics Business Region Distribution Analysis
    8.3 F. Hoffmann-La Roche Ltd.
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 F. Hoffmann-La Roche Ltd. 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 F. Hoffmann-La Roche Ltd. 2016 Candidiasis Therapeutics Business Region Distribution Analysis
    8.4 Bayer-Algeta
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Bayer-Algeta 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Bayer-Algeta 2016 Candidiasis Therapeutics Business Region Distribution Analysis
    8.5 Merrion Pharmaceuticals Plc.
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Merrion Pharmaceuticals Plc. 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Merrion Pharmaceuticals Plc. 2016 Candidiasis Therapeutics Business Region Distribution Analysis
    8.6 Ablynx
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Ablynx 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Ablynx 2016 Candidiasis Therapeutics Business Region Distribution Analysis
    8.7 Genta Incorporated
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Genta Incorporated 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Genta Incorporated 2016 Candidiasis Therapeutics Business Region Distribution Analysis
    8.8 Galapagos NV
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Galapagos NV 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Galapagos NV 2016 Candidiasis Therapeutics Business Region Distribution Analysis
    8.9 Catena Pharmaceuticals Inc.
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Catena Pharmaceuticals Inc. 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Catena Pharmaceuticals Inc. 2016 Candidiasis Therapeutics Business Region Distribution Analysis
    8.10 Digna Biotech S.L.
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Digna Biotech S.L. 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Digna Biotech S.L. 2016 Candidiasis Therapeutics Business Region Distribution Analysis
    8.11 Medivir AB
    8.12 Amura Holdings

9 Development Trend of Analysis of Candidiasis Therapeutics Market
    9.1 Global Candidiasis Therapeutics Market Trend Analysis
        9.1.1 Global 2017-2022 Candidiasis Therapeutics Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Candidiasis Therapeutics Sales Price Forecast
    9.2 Candidiasis Therapeutics Regional Market Trend
        9.2.1 North America 2017-2022 Candidiasis Therapeutics Consumption Forecast
        9.2.2 China 2017-2022 Candidiasis Therapeutics Consumption Forecast
        9.2.3 Europe 2017-2022 Candidiasis Therapeutics Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Candidiasis Therapeutics Consumption Forecast
        9.2.5 Japan 2017-2022 Candidiasis Therapeutics Consumption Forecast
        9.2.6 India 2017-2022 Candidiasis Therapeutics Consumption Forecast
    9.3 Candidiasis Therapeutics Market Trend (Product Type)
    9.4 Candidiasis Therapeutics Market Trend (Application)

10 Candidiasis Therapeutics Marketing Type Analysis
    10.1 Candidiasis Therapeutics Regional Marketing Type Analysis
    10.2 Candidiasis Therapeutics International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Candidiasis Therapeutics by Region
    10.4 Candidiasis Therapeutics Supply Chain Analysis

11 Consumers Analysis of Candidiasis Therapeutics
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Candidiasis Therapeutics Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source